Immobilization method for producing active α
View Patent ↗A method and kit for immobilization of a glycoprotein. The method may include activating an affinity support. The affinity support may be activated by reacting the affinity support with a compound that is reactive with one or more functional groups included within the glycoprotein. The method may also include oxidizing the glycoprotein in which oxidation conditions are selected to yield an oxidized glycoprotein that is biologically active and contains a sufficient number of reactive aldehyde groups for coupling to a support. For example, the oxidized glycoprotein may include five reactive aldehyde groups. In addition, the method may include reacting the oxidized-glycoprotein with the activated affinity support to immobilize the glycoprotein.
1. A method for immobilization of an alpha one (α 1 ) acid glycoprotein, comprising:
activating an affinity support, the affinity support being activated by reacting the affinity support with a compound that is reactive with one or more functional groups including within the one (α 1 ) acid glycoprotein;
oxidizing the alpha one (α 1 ) acid glycoprotein, oxidation conditions being selected to i) yield an oxidized alpha one (α 1 ) acid glycoprotein that includes at least five reactive aldehyde groups and ii) maximize activity of said alpha one (α 1 ) acid glycoprotein after oxidation, wherein said oxidation conditions comprise reacting the alpha one (α 1 ) acid glycoprotein with 5 mM to 20 mM periodate for about 10 to 15 minutes;
reacting the oxidized alpha one (α 1 ) acid glycoprotein with the activated affinity support to immobilize the alpha one (α 1 ) acid glycoprotein by linking the oxidized alpha one (α 1 ) acid glycoprotein to the activated affinity support.
2. The method as claimed in claim 1 , wherein the oxidized alpha one (α 1 ) acid glycoprotein includes five reactive aldehyde groups.
3. The method as claimed in claim 1 , wherein the activated affinity support is a hydrazide-activated support.
4. The method as claimed in claim 1 , wherein the activated affinity support is an amine-activated support.
5. The method as claimed in claim 1 , further comprising washing the immobilized alpha one (α 1 ) acid glycoprotein following reacting the oxidized alpha one (α 1 ) acid glycoprotein with the activated affinity support to remove remaining non-reacting alpha one (α 1 ) acid glycoprotein.
6. The method as claimed in claim 1 , wherein oxidation conditions include reacting the alpha one (α 1 ) acid glycoprotein with 5 mM to 20 mM periodate at room temperature.
7. The method as claimed in claim 1 , wherein the oxidation conditions include reacting the alpha one (α 1 ) acid glycoprotein with 5 mM to 20 mM periodate at about 4° C.
8. The method as claimed in claim 1 , wherein the activated affinity support is a hydrazide-activated silica support.
9. The method as claimed in claim 1 , further comprising employing the immobilized alpha one (α 1 ) acid glycoprotein for separating chiral drugs.
10. The method as claimed in claim 9 , wherein chiral drugs include propranolol.
11. The method of claim 1 , wherein said oxidation conditions comprise reacting said alpha one (α 1 ) acid glycoprotein at a concentration of about 2 to 5 milligram/milliliter.
12. The method of claim 1 , wherein said oxidation conditions comprise reacting said alpha one (α 1 ) acid glycoprotein at about pH 7.0.
13. The method of claim 1 , wherein said oxidation conditions comprise reacting said alpha one (α 1 ) acid glycoprotein at about pH 7.0 for about 10 minutes at about 4° C.